Prime Medicine Inc. (PRME)
Market Closed
1 Sep, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
3. 57
-0.02
-0.5571%
$
648.42M Market Cap
- P/E Ratio
- Div Yield
2.43M Volume
-1.83 Eps
$ 3.59
Previous Close 
Want to track PRME and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Prime Medicine Inc. (PRME) Statistics
Valuation metrics
Market Cap 648.42M
Enterprise value 717.06M
Trailing P/E (ttm) -3.28
Forward P/E -
PEG ratio -0.08
Price/Sales (ttm) 160.09
Price/Book (mrq) 16.07
Enterprise Value/Revenue 176.05
Enterprise Value/EBITDA -3.97
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 2.69M
Average volume (90 days) 3.79M
Price summary
52-Week low 2.67
52-Week high 6.94
Beta -
50-Day moving average 3.29
200-Day moving average 3.53
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -46.13%
Operating margin -48.25%
Operational effectiveness
Return on assets -0.75%
Return on equity -1.88%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.02
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.06
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.54
Total debt (mrq) -
Total Debt/Equity (mrq) 2.83
Current ratio (mrq) 3.05%
Book value per share (mrq) 0.22
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
